The Friedreich’s Ataxia Research Alliance (FARA) and Horizon Pharma plc would like to share additional background regarding the Phase 3 STEADFAST clinical trial, as well as information about our ongoing collaboration moving forward. We have received many questions among those who participated in the clinical trials, as well as others in the FA community. We want to ensure that you know we have heard your feedback, and that we are working together in the following ways.

Read more HERE